Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: Results of a pooled analysis of two randomized studies

Catheterization and Cardiovascular Interventions

Volumn 72, Issue 4, 2008, Pages 459-467

  Alfonso, Fernando ^a   Pérez Vizcayno, Maria José ^a   Hernandez, Rosana ^a   Fernandez, Cristina ^a   Escaned, Javier ^a   Bañuelos, Camino ^a   Bethencourt, Armando ^b   López Mínguez, Jose R ^c   Angel, Juan ^d   Cequier, Angel ^e   Sabaté, Manel ^f   Morís, Cesar ^g   Zueco, Javier ^h   Seabra Gomes, Ricardo ⁱ  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c HOSPITAL INFANTA CRISTINA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^g HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁱ HOSPITAL DE SANTA CRUZ   (Portugal)

Author keywords

Angiography; Angioplasty; Bare metal stents; Restenosis; Sirolimus eluting stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; METAL; RAPAMYCIN; TICLOPIDINE; CARDIOVASCULAR AGENT;

ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DEATH; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; LOADING DRUG DOSE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; AGED; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; FEMALE; INSTRUMENTATION; MALE; META ANALYSIS; MIDDLE AGED; MORTALITY; PROSTHESIS; RADIOGRAPHY; RESTENOSIS; RISK; RISK ASSESSMENT; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; METALS; MIDDLE AGED; ODDS RATIO; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 57549106330     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21694     Document Type: Article

References (23)

1. Bauters C, Banos JL, Van Belle E, Fadden EP, Lablanche JM, Bertrand ME. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation 1998;97:318-321.
2. Radke PW, Kaiser A, Frost C, Sigwart U. Outcome after treatment of coronary in-stent restenosis, Results from a systematic review using meta-analysis. techniques. Eur Heart J 2002;24: 266-273.
3. vom Dahl J, Dietz U, Haager PK, Silber S, Niccoli L, Buettner HJ, Schiele F, Thomas M, Commeau P, Ramsdale DR, Garcia E, Hamm CW, Hoffmann R, Reineke T, Klues HG. Rotational atherectomy does not reduce recurrent in-stent restenosis. Results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 2002;105:583-588.
4. Albiero R, Silber S, Di Mario C, Cernigliaro C, Battaglia S, Reimers B, Frasheri A, Klauss V, Auge JM, Rubartelli P, Morice MC, Cremonesi A, Schofer J, Bortone A, Colombo A;RESCUT Investigators. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis. Results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol 2004;43:943-949.
5. Alfonso F, Garcia P, Fleites H, Pimentel G, Sabate M, Hernandez R, Escaned J, Banuelos C, Perez-Vizcayno MJ, Moreno R, Macaya C. Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis: Angiographic and intravascular ultrasound findings of a randomized study. Am Heart J 2005;149:e1-e8.
6. Waksman R, Ajani AE, White RL, Chan R, Bass B, Pichard D, Satler LF, Kent KM, Torguson R, Deible R, Pinnow E, Lindsay J. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 2004;109:340-344.
7. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA;SISR Investigators. Sirolimus-cluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The SISR randomized trial. JAMA 2006;295:1264-1273.
8. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME;TAXUS, V ISR Investigators. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within baremetal stents: The TAXUS V ISR randomized trial. JAMA 2006;295:1253-1263.
9. Dibra A, Kastrati A, Alfonso F, et al. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: Meta-analysis of randomized trials. J Am Coll Cardiol 2007;49: 616-623.
10. Alfonso F, Perez-Vizcayno MJ, Hernandez R, Bethencourt A, Marti V, Lopez-Minguez JR, Angel J, Mantilla R, Moris C, Cequier A, Sabate M, Escaned J. Morenc R, Banuelos C, Suarez A, Macaya C; RIBS-II Investigators. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis. Results of the restenosis intrastent: Balloon angioplasty versus elective sirolimus-eluting stenting (RIBS II) trial. J Am Coll Cardiol 2006:47:2152-2160.
11. Alfonso F, Zueco J, Cequier A, Mantilla R, Bethencourt A, Lopez-Minguez JR, Angel J, Auge JM, Gomez-Recio M, Moris C, Seabra-Gomes R, Perez-Vizcayno MJ, Macaya C; Restenosis Intra-stent: Balloon Angioplasty Versus Elective Stenting (RIBS) Investigators. A randomized comparison of repeat stenting with balloon angioplasty in patients with restenosis after coronary stenting. J Am Coll Cardiol 2003;42:796-805.
12. Baz JA, Mauri J, Aibarrán A, Pinar E. Spanish Cardiac Catheterization and Coronary Intervention Registry. 6th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2006). Rev Esp Cardiol 2007;60:1273-1289.
13. Tsimikas S. Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited. J Am Coll Cardiol 2006;47:2112-2115.
14. McFadden EP, Stabile E, Regar E, Cheneau E; Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of anti-platelet therapy. Lancet 2004;364:1519-1521.
15. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
16. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis. Classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
17. Mahdi NA, Pathan AZ, Harrell L, Leon MN, Lopez J, Butte A, Ferrell M, Gold HK, Palacios IF. Directional coronary atherectomy for the treatment of Palmaz-Schatz in-stent restenosis. Am J Cardiol 1998;82:1345-1351.
18. Mehran R, Mintz GS, Satler LF, Pichard AD, Kent KM, Bucher TA, Popma JJ, Leon MB. Treatment of in-stent restenosis with excimer laser coronary angioplasty: Mechanisms and results compared with PTCA alone. Circulation 1997;96:2183-2189.
19. Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, Centemero M, Maldonado G, Abizaid AS, Pinto I, Falotico R, Jaeger J, Popma JJ, Serruys PW. Sirolimus-eluting stent for the treatment of in-stent restenosis. A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-27.
20. Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, Mugge A, Di Pede F, Fullgraf D, Aengevaeren W, Spedicato L, Popma JJ. Effectiveness and Safety of sirolimuseluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005;111:2107-2111.
21. Alfonso F, Melgares R, Mainar V, Lezaun R, Vazquez N, Tascon J, Pomar F, Cequier A, Angel J, Perez-Vizcayno MJ, Sabate M, Banuelos C, Fernandez C, Garcia JM; Restensois Intra-stent: Ballon angioplasty versus elective Stenting (RIBS) Investigators. Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial. Eur Heart J 2004;25:1829-1835.
22. Alfonso F. Residual coronary dissections after drug-eluting stenting: the good, the bad, and the ugly. Eur Heart J 2006;27: 503-505.
23. Alfonso F, Auge JM, Zueco J, Bethencourt A, Lopez-Minguez JR, Hernandez JM, Bullones JA, Calvo I, Esplugas E, Perez-Vizcayno MJ, Moreno R, Fernandez C, Hernandez R, Gama-Ribeiro V; RIBS Investigators. Long-term results (three to five years) of the Restenosis Intrastent: Balloon angioplasty versus elective Stenting (RIBS) randomized study. J Am Coll Cardiol 2005;46:756-760.